BRK-B vs NOAH
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
NOAH presents a classic 'value trap' profile, characterized by a very weak Piotroski F-Score of 2/9 indicating deteriorating fundamental health despite deep valuation discounts. While the Graham Number ($23.42) suggests significant asset-based undervaluation and the balance sheet is pristine with near-zero debt, the catastrophic collapse in earnings growth (-88.20% YoY) offsets these gains. The stock is trading near its growth-based intrinsic value ($8.12) but far below its book value, suggesting the market is pricing in significant structural risks. A sustainable dividend provides a floor, but the bearish technical trend and poor insider sentiment limit immediate upside.
Compare Another Pair
Related Comparisons
BRK-B vs NOAH: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Noah Holdings Limited (NOAH) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.